TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage
PARIS–(BUSINESS WIRE)– TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series C round of financing, raising...